Jos Jonkers

65PUBLICATIONS
368CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursTumour immunologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Sep 21, 2026
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

|Sep 18, 2026
The BRCA1 coiled-coil domain is dispensable for suppression of tandem duplications and tolerance of FANCM loss.

|Jul 13, 2026
The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy.

|May 12, 2026
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

|Mar 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Stefan J Hutten, Xue Chao, Madelon Badoux

Pageof 11

Frequent Collaborators

11 joint publications

Marieke van de Ven

10 joint publications

Sjoerd Klarenbeek

8 joint publications

Lodewyk Wessels

7 joint publications

Jinhyuk Bhin